GO
Loading...

Cramer's Mad Dash: Sarepta is 'Russian roulette'

Tuesday, 12 Nov 2013 | 9:23 AM ET

Jim Cramer explains what to watch ahead of the open, including Sarepta which is being told by the FDA not to proceed with its DMD drug.